Why involve patients

M. Rutgers (Amersfoort, Netherlands)

Source: Online Course 2014 - From research to bedside: the benefits of involving patients in respiratory healthcare
Number: 1
Disease area: Respiratory critical care

PDF journal article, handout or slidesSlide presentationMultimedia files

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Rutgers (Amersfoort, Netherlands). Why involve patients. Online Course 2014 - From research to bedside: the benefits of involving patients in respiratory healthcare

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Which functional alteration is mainly the cause in determining dyspnoeain COPD patients?
Source: Eur Respir J 2004; 24: Suppl. 48, 288s
Year: 2004

What specific issues arise in the management of elderly patients with advanced NSCLC?
Source: Annual Congress 2007 - Treatment of metastatic nonsmall cell lung cancer in the era of targeted therapies
Year: 2007


Does the diaphragm contribute to balance control in patients with COPD?
Source: Virtual Congress 2021 – An update on respiratory physiotherapy and respiratory muscle function and training
Year: 2021


COPD – what patients know about their disease and which of them require special attention
Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases
Year: 2020


Benralizumab restored expression of key molecules involved in steroid-resistance in patients with severe asthma
Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Year: 2020




Does large airway intervention for patients with malignant disease result in early clinical benefit
Source: Eur Respir J 2007; 30: Suppl. 51, 434s
Year: 2007

Does large airway intervention for patients with malignant disease result in early clinical benefit?
Source: Annual Congress 2008 - Hot and cold techniques
Year: 2008


Do oxygen-dependent patients really benefit from the service we provide?
Source: Annual Congress 2009 - MP6 - Do oxygen-dependent patients really benefit from the service we provide?
Year: 2009

What do patients expect from ERN-LUNG?
Source: International Congress 2018 – Rare lung diseases
Year: 2018


Isophonum usage in treatment of patients with pulmonary tuberculosis and accompanying pathology and elderly patients
Source: Eur Respir J 2002; 20: Suppl. 38, 547s
Year: 2002

Identifying patients with severe asthma that will be benefit from biological therapy
Source: Virtual Congress 2020 – Rethinking asthma
Year: 2020


Fatigue perception and related factors in patients with advanced sarcoidosis and COPD patients
Source: International Congress 2017 – The many faces of sarcoidosis
Year: 2017


Stage I lung cancer patients with or without symptoms – are the patients any different?
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020


COPD patients require more health care than heart failure patients
Source: International Congress 2018 – Cardiovascular morbidities in COPD
Year: 2018

How does a new breathlessness support service affect patients?
Source: Eur Respir J 2015; 46: 1515-1518
Year: 2015


How to accelerate bringing new drugs to patients: role of clinical trials networks
Source: International Congress 2019 – Rare lung diseases
Year: 2019


Factors that affect the treatment of patients with asthma
Source: Annual Congress 2010 - Treatment options for asthma
Year: 2010

Role of patients
Source: ERS Summit on priorities in respiratory medicine 2011
Year: 2011